GM-CSF aumenta la carga del VIH-1

Same author

Spatially resolved diagnostics for optimization of large ion beam sources.

The Review of scientific instruments·2022

Same author

[Choice of a two nucleos(t)ide analogs fixed dose coformulation for initial antiretroviral therapy: a rational based on virological data].

Virologie (Montrouge, France)·2021

Same author

Publisher's Note: "CRISP: A compact RF ion source prototype for emittance scanner testing" [Rev. Sci. Instrum. 91, 033314 (2020)].

The Review of scientific instruments·2020

Same author

CRISP: A compact RF ion source prototype for emittance scanner testing.

The Review of scientific instruments·2020

Same author

First operation in SPIDER and the path to complete MITICA.

The Review of scientific instruments·2020

Same author

Beam and installation improvements of the NIO1 ion source.

The Review of scientific instruments·2020

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

GM-CSF aumenta la carga del VIH-1

Videos de Conceptos Relacionados

Spatially resolved diagnostics for optimization of large ion beam sources.

[Choice of a two nucleos(t)ide analogs fixed dose coformulation for initial antiretroviral therapy: a rational based on virological data].

Publisher's Note: "CRISP: A compact RF ion source prototype for emittance scanner testing" [Rev. Sci. Instrum. 91, 033314 (2020)].

CRISP: A compact RF ion source prototype for emittance scanner testing.

First operation in SPIDER and the path to complete MITICA.

Beam and installation improvements of the NIO1 ion source.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

GM-CSF aumenta la carga del VIH-1

Videos de Conceptos Relacionados

Artículos Relacionados

Spatially resolved diagnostics for optimization of large ion beam sources.

[Choice of a two nucleos(t)ide analogs fixed dose coformulation for initial antiretroviral therapy: a rational based on virological data].

Publisher's Note: "CRISP: A compact RF ion source prototype for emittance scanner testing" [Rev. Sci. Instrum. 91, 033314 (2020)].

CRISP: A compact RF ion source prototype for emittance scanner testing.

First operation in SPIDER and the path to complete MITICA.

Beam and installation improvements of the NIO1 ion source.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.